JUAN JOSÉ
PICAZO DE LA GARZA
Investigador en el periodo 2009-2018
![Foto de JUAN JOSÉ](/img/nophoto.png)
![Foto de Hospital Universitario 12 de Octubre](/img/noimage_org.png)
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (13)
2018
-
Effects of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants aged 0 to 90 days in Madrid, Spain
Journal of the Pediatric Infectious Diseases Society
2017
-
Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015
PLoS ONE, Vol. 12, Núm. 2
-
Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children
Vaccine, Vol. 35, Núm. 35, pp. 4646-4651
2013
-
Expansion of serotype coverage in the universal pediatric vaccination calendar: Short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain
Clinical and Vaccine Immunology, Vol. 20, Núm. 10, pp. 1524-1530
-
Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011
Pediatric Infectious Disease Journal
-
Rapid diagnosis of invasive pneumococcal disease in pediatric population
Journal of Microbiological Methods, Vol. 93, Núm. 2, pp. 116-120
2012
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7
2011
-
Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: A 2-year (2007-2009) laboratory-based surveillance in Madrid
Vaccine, Vol. 29, Núm. 9, pp. 1770-1776
-
Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in madrid
Pediatric Infectious Disease Journal, Vol. 30, Núm. 6, pp. 471-474
-
Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar
Clinical and Vaccine Immunology, Vol. 18, Núm. 1, pp. 89-94
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
2003
-
Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)
Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 421-427